Serial #88314384
DEAD

Serial Number

88314384

Owner

Egg Rock Holdings, LLC

Attorney

Kamran Fattahi

Filing Date

Feb 25, 2019

Add to watchlist:

No watchlists yet
View on USPTO

Serial #88314384 Trademark

Serial Number: 88314384

Serial #88314384 is a trademark filed by Egg Rock Holdings, LLC on February 25, 2019. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Egg Rock Holdings, LLC (46 trademarks)

350 North Glendale Avenue, Suite B123
Glendale, CA 91206

Entity Type: 16

MAMMOTH MANAGEMENT, INC. (21 trademarks)

11941 VOSE ST.
NORTH HOLLYWOOD, CA 91605

Entity Type: 03

Trademark Details

Filing Date

February 25, 2019

Registration Date

Not Registered

Published for Opposition

December 26, 2023

Goods & Services

Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabichromene solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabielsoin solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabinol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabinodiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabidiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabicitran solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabimovone solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabichromene solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabielsoin solely derived from Cannabis sativa L. with a delta9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabinol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabinodiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabidiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabicitran solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabimovone solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabichromene solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabielsoin solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabinol solely derived from Cannabis sativa L. with a delta9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabinodiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabidiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabicitran solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabimovone solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient, all of the foregoing containing no cannabis and no cannabinoids

Essential oils for cosmetic purposes, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Essential oils for cosmetic purposes, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils in drop form, capsule form, and liquid form, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils in drop form, capsule form, and liquid form, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments in drop form and liquid form, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments in drop form and liquid form, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Non-medicated body soaks, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Nonmedicated body soaks, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Electronic cigarette liquid (e-liquid) comprised of essential oils, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Electronic cigarette liquid (e-liquid) comprised of essential oils, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 24, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 24, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 24, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 24, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 24, 2025 COAR
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 17, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 17, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 7, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jul 7, 2025 EX2G
SOU EXTENSION 2 FILED
Feb 5, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 5, 2025 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 13, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 13, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 13, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 13, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 13, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 13, 2024 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 29, 2024 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 8, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jul 8, 2024 EX1G
SOU EXTENSION 1 FILED
Jul 8, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 8, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 20, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 26, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 26, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 6, 2023 NONP
EXPARTE APPEAL TERMINATED
Nov 20, 2023 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2023 CNSA
JURISDICTION RESTORED TO EXAMINING ATTORNEY
May 2, 2023 JURT
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Feb 25, 2023 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Feb 25, 2023 GECD
ACTION CONTINUING FINAL - COMPLETED
Feb 25, 2023 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 20, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 2022 CRFA
ASSIGNED TO LIE
Oct 20, 2022 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 14, 2022 ERFR
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jun 28, 2022 JURT
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Apr 14, 2022 GNS1
SUBSEQUENT FINAL EMAILED
Apr 14, 2022 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Apr 14, 2022 CFRC
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 22, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 22, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 26, 2021 GNRN
NON-FINAL ACTION E-MAILED
Apr 26, 2021 GNRT
NON-FINAL ACTION WRITTEN
Apr 26, 2021 CNRT
DIVISIONAL PROCESSING COMPLETE
Dec 23, 2020 DPCC
DIVISIONAL PROCESSING COMPLETE
Dec 23, 2020 DPCC
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 15, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 15, 2020 CRFA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 15, 2020 TEME
DIVISIONAL REQUEST RECEIVED
Dec 14, 2020 DRRR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 14, 2020 CRFA
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 14, 2020 PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 14, 2020 PARI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Dec 14, 2020 JURT
EX PARTE APPEAL-INSTITUTED
Dec 14, 2020 EXPI
EXPARTE APPEAL RECEIVED AT TTAB
Dec 14, 2020 EXAF
TEAS REQUEST TO DIVIDE RECEIVED
Dec 14, 2020 ERTD
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 13, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 13, 2020 GNFN
FINAL REFUSAL E-MAILED
Jun 13, 2020 GNFR
FINAL REFUSAL WRITTEN
Jun 13, 2020 CNFR
DIVISIONAL PROCESSING COMPLETE
May 11, 2020 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 11, 2020 AITU
TEAS/EMAIL CORRESPONDENCE ENTERED
May 11, 2020 TEME
ASSIGNED TO LIE
May 4, 2020 ALIE
DIVISIONAL REQUEST RECEIVED
Apr 29, 2020 DRRR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 29, 2020 TROA
TEAS REQUEST TO DIVIDE RECEIVED
Apr 29, 2020 ERTD
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 29, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 29, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 29, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 28, 2019 DOCK
ASSIGNED TO EXAMINER
May 6, 2019 DOCK
ASSIGNED TO EXAMINER
May 6, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 21, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 15, 2019 NWOS
NEW APPLICATION ENTERED
Feb 28, 2019 NWAP